Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Years of evidence have indicated that the Church has contributed to the spread of misinformation and HIV-related ...

The national health department has tried to reassure the public that the country’s HIV response is mostly funded by the ...

After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding.

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Mayor Daniel Lurie signed an executive order aimed at consolidating services he thinks are not doing enough to help the ...

While poppers have previously been incorrectly linked to AIDS in the LGBTQ+ community — an unfounded stance Robert F. Kennedy ...

IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...

Newsday Zimbabwe The agreements for the projects were signed yesterday between Shinichi Yamanaka, ambassador of Japan to ...

Children, pregnant women, study participants with certain skin conditions or substantially suppressed immune ... observed in ...